# ClinicalTrials.gov record NCT01116401

> PeptideScanner retained ClinicalTrials.gov record NCT01116401 at 2026-07-30T21:12:47.405Z. Its registry update date was 2018-01-23, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct01116401-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-01-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01116401-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01116401-leuprolide-v1.json
- Content SHA-256: `332efa6f07ad594d9868e31e2e16f4dde81f39e4306281ee6faf43e56a771887`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01116401 ([`ctg-observation-nct01116401-2018-01-23-5662ad964406`](#source-ctg-observation-nct01116401-2018-01-23-5662ad964406))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01116401 at 2026-07-30T21:12:47.405Z. Its registry update date was 2018-01-23, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01116401-2018-01-23-5662ad964406`](#source-ctg-observation-nct01116401-2018-01-23-5662ad964406))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01116401 at 2026-07-30T21:12:47.405Z. Its registry update date was 2018-01-23, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01116401-2018-01-23-5662ad964406`](#source-ctg-observation-nct01116401-2018-01-23-5662ad964406))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01116401-2018-01-23-5662ad964406`](#source-ctg-observation-nct01116401-2018-01-23-5662ad964406))

## Sources

<a id="source-ctg-observation-nct01116401-2018-01-23-5662ad964406"></a>
- **ClinicalTrials.gov record NCT01116401 · retained source version 2018-01-23:5662ad964406f5c3b034e0b1c388212858317bf068b4d1be51c3bee19d2253d7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01116401) (`ctg-observation-nct01116401-2018-01-23-5662ad964406`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01116401." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01116401-leuprolide-v1.json SHA-256: 332efa6f07ad594d9868e31e2e16f4dde81f39e4306281ee6faf43e56a771887.